“The department of Ayush has approached the General Insurance Council for looking at the possibility of accepting claims under the non-allopathic means of treatment,” said a person familiar with the development at the Council. “They made a presentation to council members, who in turn, have formed a three-member committee to look into the matter.”

The committee comprises chief executive officers from Star Health, Max Bupa and Apollo, the person said. It would examine the merits and demerits of the proposal and recommend processes to implement if it is convinced that these types of medicines should also be covered under health insurance. The Insurance Regulatory & Development Authority will take a call on the issue.

Though a large section of India’s population rely on alternative forms of treatments and medicine, the Insurance industry doesn’t seem to have recognized its importance. Insurers say that there is no established way to verify or enough data to rely on to confirm these claims.

“Under allopathic means of treatment, there are scientific studies and we know how long a treatment will take, how much will it cost,’’ said TA Ramalingam, head of underwriting, Bajaj Allianz General Life Insurance. “But under the alternative means like homeopathy, we do not have enough data to cover them. For example, curing an ailment under homeopathy may take years, we would not have a structured way of looking at data. But under allopathic means of treatment, it’s more immediate, and hence, easily manageable” he adds.

But the health and family welfare ministry is pushing hard for it as it is affordable and the majority of the population makes use of the domestic expertise in these areas. Allopathic medicines are expensive even for those who are in urban centers.

On account of this the Secretary of the Department of AYUSH, S Jalaja, said the department was striving to popularize Ayurveda. “More colleges are being set up and preparations are on to upgrade the syllabus, create basic infrastructure and teaching staff to ensure quality education,” she said. She also added that the main intention of the congress was to standardize and integrate health and tourism and also to create a global market for Ayurveda.

The global meet is expected to attract 4,000 delegates from 34 countries and several state governments, institutions, NGOs, practitioners, drug manufacturers and cultivators. Those expected to address the summit, include Ghulam Nabi Azad and Chief Minister B S Yeddyurappa.

This certification is issued by the Ayush department of the union Ministry of Health and Family Welfare for product quality, efficacy, authenticity and toxicity.

The Kerala-based company has received the certification for three of its products in the Fast Moving Consumer Goods (FMCG) category which includes Dhathri Real Slim oil, Chemparathi Thali and Dheedhi Shampoo.

‘This reiterates our commitment in assuring extremely good quality for our end products, which we assure through stringent quality checks”,  Sajikumar, Managing Director, Dhathri Ayurveda, told reporters here.

A project for Physico chemical characterization and toxicity studies of 8 widely used Bhasmas (Rasa Aushadhies) was also sanctioned under the Golden Triangle Project which is being carried out by various laboratories of CSIR i.e. Indian Institute of Toxicological Research (IITR), Lucknow, Indian Institute of Chemical Technology (IICT), Hyderabad. Under this project, one of the reputed manufacturers of Rasa Aushadhies was chosen for manufacturing of the selected Rasa Aushadhies as per the classical texts which were made available to CSIR laboratories for physio chemical characterization and their toxicity studies. On the basis of 28 days toxicity studies, all the 8 Rasa Aushadhies have been found to be non-toxic. 90 days chronic studies are under progress. CSIR would be getting the results of this scientific research published to set at rest doubts regarding the safety of Rasa Aushadhies prepared properly as per classical texts. Further, the work of finalizing SOPs for the various herbo metallic compounds (Rasa Aushadhies) used in Ayurveda has been undertaken by the Ayurvedic Pharmacopoeia Committee of India. Supplementary Good Manufacturing Practices for Rasa Aushadhies have also been prepared of which draft publication has been done.

Samples of 600 Indian medicinal plants collected from the wild as well as various medicinal plant gardens in India by the Council for Scientific Research in Ayurveda and Siddha were sent to the Indian Institute of Toxicological Research (CSIR), Lucknow, Sri Ram Institute of Industrial Toxicology, New Delhi and Centre for Research in Indian Medicine, Shastra University, Thanjavur. The test reports received from these three laboratories disclose that Lead, Mercury and Arsenic have not been found in these 600 Indian medicinal plants samples above the permissible limits laid down by WHO which is 10ppm for Lead, 1ppm for Mercury and 3ppm for Arsenic. This study clearly indicates that Indian medicinal plants collected from the wild or cultivated have been found to be free from lead, mercury and arsenic contamination contrary to the claim made by Dr. Robert Saper et al in their second article “Lead, Mercury and Arsenic in US- and Indian- Manufactured Ayurvedic Medicines sold via the Internet” published in JAMA, August 27, 2008.

The bias of Dr. Saper against Ayurvedic medicines becomes very apparent from the fact that he has included even those Ayurvedic medicines being sold in USA in Table 3 of the above mentioned article in which lead is below WHO’s maximum permissible limit of 10ppm. Further, as per Dr. Saper’s article, these medicines are sold by internet which does not indicate the source of their origin. Further, some of the medicines mentioned in Table 3 of the article, namely Akangvir Ras, Agnitundi Bati, Arogyavardhini Bati are herbo metallic compounds which contain these metals as therapeutic agents after purification process. Dr. Saper has visited India and has been in touch with several Ayurveda experts and is fully aware that these herbo-metallic preparations used in Ayurvedic system of medicine contain heavy metals like lead, mercury and arsenic as therapeutic agents after proper de-toxification process and no significant adverse drug reactions have been reported regarding their use in India. Dr. Saper is also fully aware that a high level scientific research is being undertaken in India for physio chemical characterization and safety of herbo metallic preparations for Rasa Aushadhies.

It needs to be emphasized that as per the directions issued by Department of AYUSH, herbo metallic compounds are not being officially exported because of heavy metal concerns and only purely herbal Ayurveda, Unani and Siddha medicines are being exported from India with effect from 1.1.2006 after certification of heavy metals below the permissible limit by the manufacturing unit. In view of the above, the above mentioned article of Dr. Saper and his associates is seriously flawed and discloses a strong bias against Ayurvedic medicines. Indian scientists and research institutions will be responding to the issues raised by Dr. Saper, howsoever flawed they may be, through research articles based on their work on Ayurvedic medicines in due course.